{
  "pmid": "28930510",
  "uid": "28930510",
  "title": "The Fate of FDA Postapproval Studies.",
  "abstract": "",
  "authors": [
    {
      "last_name": "Woloshin",
      "fore_name": "Steven",
      "initials": "S",
      "name": "Steven Woloshin",
      "affiliations": [
        "From the Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH (S.W., L.M.S.); AtlantiCare Regional Medical Center, Pomona, NJ (B.W.) ; the Institute for Safe Medication Practices, Alexandria, VA (T.J.M.); and the Department of Epidemiology and Biostatistics, George Washington University Milken Institute School of Public Health, Washington, DC (T.J.M.)."
      ]
    },
    {
      "last_name": "Schwartz",
      "fore_name": "Lisa M",
      "initials": "LM",
      "name": "Lisa M Schwartz",
      "affiliations": [
        "From the Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH (S.W., L.M.S.); AtlantiCare Regional Medical Center, Pomona, NJ (B.W.) ; the Institute for Safe Medication Practices, Alexandria, VA (T.J.M.); and the Department of Epidemiology and Biostatistics, George Washington University Milken Institute School of Public Health, Washington, DC (T.J.M.)."
      ]
    },
    {
      "last_name": "White",
      "fore_name": "Brian",
      "initials": "B",
      "name": "Brian White",
      "affiliations": [
        "From the Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH (S.W., L.M.S.); AtlantiCare Regional Medical Center, Pomona, NJ (B.W.) ; the Institute for Safe Medication Practices, Alexandria, VA (T.J.M.); and the Department of Epidemiology and Biostatistics, George Washington University Milken Institute School of Public Health, Washington, DC (T.J.M.)."
      ]
    },
    {
      "last_name": "Moore",
      "fore_name": "Thomas J",
      "initials": "TJ",
      "name": "Thomas J Moore",
      "affiliations": [
        "From the Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH (S.W., L.M.S.); AtlantiCare Regional Medical Center, Pomona, NJ (B.W.) ; the Institute for Safe Medication Practices, Alexandria, VA (T.J.M.); and the Department of Epidemiology and Biostatistics, George Washington University Milken Institute School of Public Health, Washington, DC (T.J.M.)."
      ]
    }
  ],
  "journal": {
    "title": "The New England journal of medicine",
    "iso_abbreviation": "N Engl J Med",
    "issn": "1533-4406",
    "issn_type": "Electronic",
    "volume": "377",
    "issue": "12",
    "pub_year": "2017",
    "pub_month": "Sep",
    "pub_day": "21"
  },
  "start_page": "1114",
  "end_page": "1117",
  "pages": "1114-1117",
  "language": "eng",
  "publication_types": [
    "Journal Article"
  ],
  "keywords": [
    "Clinical Trials, Phase IV as Topic",
    "Databases, Factual",
    "Drug Approval",
    "Humans",
    "Product Surveillance, Postmarketing",
    "United States",
    "United States Food and Drug Administration"
  ],
  "article_ids": {
    "pubmed": "28930510",
    "doi": "10.1056/NEJMp1705800"
  },
  "doi": "10.1056/NEJMp1705800",
  "dates": {
    "completed": "2017-09-26",
    "revised": "2017-12-19"
  },
  "chemicals": [],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:57:03.544423",
    "pmid": "28930510"
  }
}